MSF response to Gavi investment in rollout of RTS,S malaria vaccine

Gavi, the Vaccine Alliance, has just announced that it will award part (US$75 million) of the remaining $262 million of the Advance Market Commitment (AMC)—a $1.5 billion fund that was launched in 2009 to pay for the introduction of ...

Global vaccines community must do everything it can to help introduce the new, more affordable pneumonia vaccine in all countries, especially middle-income countries

As Gavi, the Vaccine Alliance, starts to commemorate its 20th year and launches a new fundraising appeal, MSF stresses that more must be done to make sure the 55 million children who do not have access to the pneumonia vaccine are ...

The World Health Organization (WHO) has just quality assured a third pneumococcal conjugate vaccine (PCV), manufactured by the Serum Institute of India, that protects children against certain types of pneumonia and will be much more ...

Miriam Alia is an Intensive Care Paediatric Nurse who has been working with MSF since 2005. She’s currently working as a Vaccination Advisor for MSF, after a stint as a Medical Coordinator in MSF teams deployed in emergency situations ...

Ahead of this week’s board meeting of Gavi, MSF calls on board members to immediately stop paying out funds from a remaining US$262 million subsidy to the pharmaceutical corporations Pfizer and GlaxoSmithKline (GSK) for the ...

After a decade of strong commitments to fight the twin epidemics of HIV and tuberculosis (TB), a decline in international funding and the rapid shifting of the financial burden to affected countries is in danger of reversing lifesaving ...

More children can be protected against the number one childhood killer disease if Gavi reserves its special funding to promote a new affordable version of pneumonia vaccine

Medical humanitarian organisation uses ‘Humanitarian Mechanism’ programme to access affordable versions of pneumonia vaccine to protect refugee children in Greece against the number one childhood killer worldwide

In this interview, Kate Elder, the Access Campaign’s Vaccines Policy Advisor who worked on the “A Fair Shot” campaign, talks about what this public advocacy and action achieved, and the lessons learned.

Protecting as many children as possible in an emergency context